February 2026
The global diabetes associated ophthalmic treatment market size was evaluated at USD 6.91 billion in 2025 and is predicted to hit around USD 12.65 billion by 2035, growing at a CAGR of 6.24%.
June 2026
The global nasal polyposis treatment market size is evaluated at USD 5.27 billion in 2025 and is predicted to hit around USD 9.69 billion by 2035, growing at a CAGR of 6.28%.
June 2026
The global celiac disease treatment market size is evaluated at USD 784.59 million in 2025 and is predicted to hit around USD 2,400.49 million by 2035, growing at a CAGR of 11.83%.
June 2026
The ear nose throat (ENT) treatment market size was estimated to hit around USD 35.15 billion by 2035 increasing from USD 19.96 billion in 2025, with a CAGR of 5.82%.
June 2026
The asthma treatment market size accounted for USD 28.96 billion in 2025 and is expected to hit around USD 36.8 billion by 2035, poised to grow at a CAGR of 2.42%.
June 2026
The digital diabetes management market size was recorded at USD 37.89 billion in 2025 and is projected to cross around USD 192.91 billion by 2035, at a CAGR of 17.67%
June 2026
The US glioblastoma multiforme treatment market size was evaluated at USD 789.54 million in 2025 and is predicted to hit around USD 1,634.84 million by 2035, growing at a CAGR of 7.55%.
June 2026
The global fixed-dose combination diabetes drugs market gain insights into market dynamics, competitive strategies and future projections for fixed-dose combination therapies designed to meet complex diabetes treatment needs.
June 2026
The global acne treatment market size was valued at USD 12.37 billion in 2025 and is expected to hit around USD 20.99 billion by 2035, growing at a CAGR of 5.60%.
June 2026
The diabetes management technologies market is set to grow significantly by 2035, driven by innovations in glucose monitoring, insulin delivery, and digital health solutions.
June 2026
The global renal failure treatment market size is accounted to hit around USD 281.02 billion by 2035 increasing from USD 132.28 billion in 2025, with a CAGR of 7.83%.
June 2026
The global lymphoma treatment market size was evaluated at USD 8.08 billion in 2025 and is predicted to hit around USD 17.81 billion by 2035, growing at a CAGR of 8.22%.
June 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
June 2026
The solid tumor cancer treatment market size was valued at USD 5.64 billion in 2025 and is projected to hit around USD 9.14 billion by 2035 with a CAGR of 4.95%.
June 2026
The global oral mucositis treatment market size is estimated to hit around USD 3.96 billion by 2035 increasing from USD 1.99 billion in 2025, with a CAGR of 7.12%.
June 2026
The global neuroendocrine tumor treatment market size is estimated to surpass around USD 5.16 billion by 2035 from USD 2.88 billion in 2025, at a solid CAGR of 6.00%.
June 2026
The global respiratory disorders treatment market size is estimated to surpass around USD 218.05 billion by 2035 from USD 121.01 billion in 2025 with a CAGR of 6.07%.
June 2026
The global prediabetes market size is calculated at USD 322.14 million in 2025 and is estimated to hit around USD 635.6 million by 2035 with a CAGR of 7.03%.
June 2026
The US diabetic foot ulcer treatment market size was evaluated at USD 3.66 billion in 2025 and is predicted to hit around USD 6.58 billion by 2035, growing at a CAGR of 6.04%.
June 2026
The global chronic smell and flavor loss treatment market size is projected to surge around USD 6.70 billion by 2035 from USD 3.65 billion in 2025 with a CAGR of 6.26%.
June 2026
The global rotator cuff injury treatment market size was evaluated at USD 1.39 billion in 2025 and is predicted to hit around USD 2.35 billion by 2035, growing at a CAGR of 5.37%.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
June 2026
The U.S. systemic inflammatory response syndrome treatment market size was evaluated at USD 4.88 billion in 2025 and is predicted to hit around USD 8.83 billion by 2035, growing at a CAGR of 6.11%.
June 2026
The global phototherapy treatment market size is estimated to hit around USD 2.68 billion by 2035 increasing from USD 1.77 billion in 2025, with a CAGR of 4.53%.
June 2026
The global knee osteoarthritis injectable treatments market size is estimated to hit around USD 6.78 billion by 2035 from USD 3.46 billion in 2025, with a CAGR of 6.96%.
June 2026
The U.S. non-invasive aesthetic treatment market size is projected to hit around USD 16.43 billion by 2035, from USD 8.03 billion in 2025, with a notable CAGR of 7.42%.
June 2026
The global liver fibrosis treatment market size is estimated to hit around USD 57.11 billion by 2035 from USD 20.35 billion in 2025, with a solid CAGR of 10.87%.
June 2026
The global mucopolysaccharidosis treatment market size is estimated to surge around USD 11.49 billion by 2035 increasing from USD 4.19 billion in 2025, with a CAGR of 10.61%.
June 2026
The global diabetes devices market size accounted for USD 35.26 billion in 2025 and is projected to hit around USD 73.43 billion by 2035, growing at a CAGR of 7.61%.
June 2026
The global mouth ulcer treatment market size was calculated at USD 1.68 billion in 2025 and is expected to worth around USD 2.46 billion by 2035 with a CAGR of 3.89%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com